Articles Posted in Mass Torts

by

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died. The infections were caused by drug-resistant bacteria that no antibiotic could reliably kill. The patients had gone into the hospital for routine diagnostic procedures–gallstone evaluations, pancreatic biopsies, bile duct imaging–and came out with infections that would destroy their organs, land them in intensive care for months, or kill them outright.

The remarkable part is not that it happened. Medical devices fail. Infections occur. What makes the Olympus duodenoscope litigation extraordinary is that the company knew. Olympus knew its scopes could not be adequately cleaned. Olympus knew that bacteria were surviving the sterilization process and spreading from patient to patient. Olympus knew that people were dying. And for years, the company did almost nothing.

This page explains what went wrong, why it went wrong, and the legal options available to patients and families harmed by contaminated Olympus scopes. It is long. It is detailed. It is written for people who want to understand not just the claims being filed, but the science, the regulatory failures, and the corporate decisions that turned a solvable engineering problem into a public health catastrophe.

Continue reading

by

This page is for victims considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates on these claims, explain the litigation process, and predict Depo Provera settlement amounts.

A new scientific study has provided stunning evidence that using Depo-Provera can cause brain tumors. Women who used Depo-Provera and subsequently developed a meningioma brain tumor can file a Depo-Provera lawsuit seeking financial compensation. This new evidence is leading to a wave of Depo-Provera lawsuits nationwide.

Our lawyers are speaking to over 100 women a week who used Depo-Provera and have been diagnosed with meningioma. Our law firm is committed to this litigation and handling Depo-Provera lawsuits for women who had at least two injections and were later diagnosed with a meningioma brain tumor. If you meet these criteria, we will make the process of signing up for this litigation easy for you. Contact our Depo-Provera lawyers today at 800-553-8082 or contact us online.

Continue reading

by

This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest news on social media class action lawsuits.

The problem that led to social media lawsuits is that millions of people, too many of whom are children, are addicted to social media platforms such as Facebook, Instagram, Snapchat, and others. For these vulnerable users, social media addiction can be very harmful and lead to things like eating disorders, depression, and, in some cases, suicide.

Now, these companies are facing a wave of new social media lawsuits alleging that they knowingly designed the algorithms of their platforms to lure young people into harmful addictions.

Continue reading

by

Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.

Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.

Continue reading

by

Our law firm  was handling Philips CPAP machine lawsuits for injuries from the recalled Philips CPAP machine.

The Philips recall covered an estimated 3.5 million sleep apnea devices. A CPAP class action lawsuit with thousands of plaintiffs has been consolidated into a multi-district litigation (MDL-1230). So, every Philips CPAP lawsuit in federal court—filed in New York, California, Texas, or wherever—was consolidated in federal court in Pennsylvania.

After the settlement, we are no longer reviewing new cases.

Continue reading

by

This page provides Camp Lejeune lawsuit updates. Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.

Continue reading

by

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

Lawyers across the country are now reviewing Dupixent lawsuits on behalf of patients who developed CTCL, mycosis fungoides, or Sézary syndrome after receiving Dupixent injections.

Continue reading

by

Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading